Abstract
Ten haemodialysis (HD) patients with a median residual creatinine clearance (CLCR) of 1.9 ml·min−1·1.73 m−2 (range 0.6–5.3) were treated with oral furosemide (F) 2.0 g. Overall-efficiency (O-E, daily sodium excretion/total urinary F) and total-efficiency (Δ-E, increase in daily sodium excretion/total urinary F) were measured on the last 24 hours of each interdialysis interval. In addition, O-E was measured during the complete interdialysis interval in 10 HD patients with a median CLCR of 5.6 ml·min−1·1.73 m−2 (range 0.7–6.8) treated for 1 year with a fixed oral dose of F between 250–1000 mg (median 625 mg).
In the short study the median O-E was 10.6 mmol·mg−1 (range 1.9–22.0) and Δ-E 6.2 mmol·mg−1 (range 1.3–11.2). The fractional excretion of sodium FENa was significantly increased from 9.6% (range 4.1–22.9) to 27% (range 14.6–56.2) during F treatment. A positive correlation was found between the basal FENa and Δ-E. In the long-term study median O-E was 6.4 mmol·mg−1. O-E and FENa showed no change over time although median RCC decreased from 5.6 to 1.9 ml·min−1·1.73 m−2 and median F excretion from 11.8 to 7.5 mg per day.
It can be concluded that diuretic efficiency in haemodialysis patients is dependent on FENa and the state of hydration during the interdialysis interval.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Allison MEM, Kennedy AC (1971) Diuretics in chronic renal disease: a study of high dosage furosemide. Clin Sci 41:171–187
Vereerstraeten PJC, Dupuis F, Toussaint C (1975) Effects of large doses of furosemide in end-stage chronic renal failure. Nephron 14:333–338
Schmidt P, Loew D, Dycka J, Kopse H, Balcke P, Zazgornic J, Deutsch E (1981) Comparison of the effects of muzolemine and furosemide in patients with end-stage renal failure on chronic dialysis. Eur J Clin Pharmacol 20:23–26
Stolear IC, Achammer I, Georges B (1990) The efficacy of torasemide in the treatment of patients with high-grade renal failure on dialysis. In: Krück, et al (eds) Torasemide: clinical pharmacology and clinical applications. Progr Clin Pharmacol 8:259–267
Schulz W, Dorfler A, Stiehl L, Achammer I (1990) Double-blind clinical trial investigating the efficacy of long term tolerance of torasemide 200 mg p.o. compared with furosemide 500 mg p. o. and placebo p. o. in patients with chronic renal failure on haemodialysis, a multi-centre study. In: Krück, et al (eds) Torasemide: clinical pharmacology and clinical applications. Progr Clin Pharmacol 8:250–257
Van Olden RW, Van Meyel JJM, Gerlag PGG (1992) Acute and long-term effects of therapy with high-dose furosemide in chronic haemodialysis patients. Am J Nephrol 12:351–356
Kaojarern S, Day B, Brater DC (1982) The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int 22:69–74
Brater DC (1993) Diuretic resistance in patients with chronic renal insufficiency. In: Puschet JB, Greenberg A (eds) Diuretics. IV. Chemistry, Pharmacology and Clinical Applications. Elsevier, Amsterdam, pp 417–425
Hammarlund-Udenaes MM, Benet LZ (1989) Furosemide pharmaco-kinetics and pharmacodynamics in health and disease — an update. J Pharmacokinet Pharmacol 17:1–46
Alván G, Paintaud G, Eckernäs SrA, Grahnén A (1992) Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect. Br J Clin Pharmacol 34:47–52
Voelker JR, Brown-Cartwright D, Anderson S, Leinfelder J, Sica DA, Kokko JP, Brater DC (1987) Comparison of loop diuretics in patients with chronic renal insufficiency: mechanism of difference in response. Kidney Int 32:572–578
Brater DC, Anderson SA, Brown-Cartwright D (1986) Response to furosemide in chronic renal insufficiency: rationale for limited doses. Clin Pharmacol Ther 40:134–139
Brater DC (1990) Clinical pharmacology of loop diuretics. Drugs 41 [Suppl 3]:14–22
Kerremans ALM, Tan Y, Van Ginneken CAM, Gribnau FWJ (1982) Specimen handling and high-performance liquid chromatographic determination of furosemide. J Chromatogr 229:129–139
Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH (1975) Measurement of residual glomerular filtration rate in patients receiving repetitive haemodialysis. Kidney Int 8:185–190
Alván G, Helleday L, Lindholm A, Sanz E, Villén T (1990) Diuretic effect and diuretic efficiency after intravenous dosage of frusemide. Br J Clin Pharmacol 29:215–219
Alván G, Hammarlund-Udenaes M, Odlind B (1991) The validity of the sigmoid Emax model and efficiency concept in diuretic studies. Br J Clin Pharmacol 31:210
Holford NHG, Sheiner LB (1981) Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6:429–453
Hammarlund MM, Odlind B, Paalzow LK (1985) Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 233:447–453
Andreasen F, Norager Lauridsen I, Hansen FA, Christensen S, Steiness E (1988) Dose dependency of furosemide-induced sodium excretion. J Pharmacol Exp Ther 248:1182–1188
Van Meyel JJM, Smits P, Russel FGM, Gerlag PGG, Tan Y, Gribnau FWJ (1992) Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin Pharmacol Ther 51:440–444
Bricker NS, Fine LG, Kaplan M, Epstein M, Bourgoignie JJ, Light A (1978) “Magnification phenomenon” in chronic renal disease. NEJM 299:1287–1293
Oliver J (1950) When is the kidney not a kidney? J Urol 63:373–402
Loon NR, Wilcox CS, Unwin RJ (1989) Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36:682–689
Rose BD (1989) Clinical Physiology of Acid-base and Electrolyte Disorders, 3rd edn. McGraw-Hill, New York, pp 109–111
Brater DC (1985) Resistance to loop diuretics: why it happens and what to do about it. Drugs 30:427–443
De Sommers K, Meyer EC, Moncrieff J (1991) The influence of co-aministered organic acids on the kinetics and dynamics of frusemide. Br J Clin Pharmacol 32:489–493
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Olden, R.W., van Meyel, J.J.M. & Gerlag, P.G.G. Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency. Eur J Clin Pharmacol 47, 483–488 (1995). https://doi.org/10.1007/BF00193698
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00193698